-
1Academic Journal
Authors: Yohei Ishibashi, Noriaki Takama, Yoichi Ohtaki, Norimichi Koitabashi, Masahiko Kurabayashi, Hideki Ishii
Source: Internal Medicine; 2024, Vol. 63 Issue 10, p1387-1393, 7p
-
2Academic Journal
Authors: Takashi Nagasaka, Noriaki Takama, Yoshiaki Ohyama, Norimichi Koitabashi, Shoichi Tange, Masahiko Kurabayashi
Source: Internal Medicine; 2021, Vol. 60 Issue 22, p3551-3558, 8p
-
3Academic Journal
Authors: Yae Matsuo, Shu Kasama, Takuji Toyama, Ryuichi Funada, Noriaki Takama, Norimichi Koitabashi, Shuichi Ichikawa, Yasuyuki Suzuki, Naoya Matsumoto, Yuichi Sato, Masahiko Kurabayashi
Source: Open Heart (2053-3624); 2/2/2016, Vol. 3 Issue 1, p1-9, 9p
-
4Academic Journal
Authors: Norimichi Koitabashi, Nogiku Niwamae, Tetsuya Taguchi, Yoshiaki Ohyama, Noriaki Takama, Masahiko Kurabayashi
Source: Thrombosis Journal; 2015, Vol. 13 Issue 1, p1-6, 6p
Subject Terms: VENOUS thrombosis treatment, PULMONARY embolism, VENOUS insufficiency, FEMORAL vein, MAY-Thurner syndrome, ANTICOAGULANTS, DRUG therapy, COMPUTED tomography, HOSPITAL admission & discharge, ILEUM, EVALUATION of medical care, ORAL drug administration, PATIENTS, REGRESSION analysis, THROMBOSIS, DIAGNOSIS, RIVAROXABAN, ANATOMY, EMBOLISM risk factors, THERAPEUTICS, DISEASE risk factors
-
5Academic Journal
Authors: Noriaki Takama, Masahiko Kurabayashi
Source: Journal of Cardiology; Mar/Apr2014, Vol. 62 Issue 3/4, p302-307, 6p